300 related articles for article (PubMed ID: 23329540)
1. Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
Adlan AM; Lip GY
Drug Saf; 2013 Feb; 36(2):93-110. PubMed ID: 23329540
[TBL] [Abstract][Full Text] [Related]
2. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
Schweizer PA; Becker R; Katus HA; Thomas D
Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
[TBL] [Abstract][Full Text] [Related]
3. Dronedarone: a promising alternative for the management of atrial fibrillation.
Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
[TBL] [Abstract][Full Text] [Related]
4. Dronedarone.
Tamargo J; López-Farré A; Caballero R; Delpón E
Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
[TBL] [Abstract][Full Text] [Related]
5. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
Pamukcu B; Lip GY
Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
[TBL] [Abstract][Full Text] [Related]
6. Dronedarone for atrial fibrillation: a new therapeutic agent.
Patel PD; Bhuriya R; Patel DD; Arora BL; Singh PP; Arora RR
Vasc Health Risk Manag; 2009; 5():635-42. PubMed ID: 19688104
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dronedarone: a review of randomized trials.
Christiansen CB; Torp-Pedersen C; Køber L
Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
[TBL] [Abstract][Full Text] [Related]
9. Dronedarone: an overview.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
[TBL] [Abstract][Full Text] [Related]
10. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
11. Dronedarone--a new alternative for management of atrial fibrillation.
Hundal M; Garg RK
Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):47-53. PubMed ID: 20001929
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation.
Khan MH; Rochlani Y; Aronow WS
Expert Opin Drug Saf; 2017 Dec; 16(12):1407-1412. PubMed ID: 28960089
[TBL] [Abstract][Full Text] [Related]
13. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
14. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
Naccarelli GV; Kowey PR
Curr Cardiol Rev; 2014 Nov; 10(4):303-8. PubMed ID: 24821656
[TBL] [Abstract][Full Text] [Related]
15. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
Garcia D; Cheng-Lai A
Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
[TBL] [Abstract][Full Text] [Related]
16. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
Duray GZ; Schmitt J; Hohnloser SH
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of dronedarone as a therapeutic option for patients with atrial fibrillation.
Lee EJ; Kim J
J Clin Pharm Ther; 2014 Apr; 39(2):112-7. PubMed ID: 24738113
[TBL] [Abstract][Full Text] [Related]
18. Dronedarone-current status in management of atrial fibrillation.
Manakshe G; Rao BH
Indian Heart J; 2012; 64(2):182-6. PubMed ID: 22572497
[TBL] [Abstract][Full Text] [Related]
19. Dronedarone in high-risk permanent atrial fibrillation.
Connolly SJ; Camm AJ; Halperin JL; Joyner C; Alings M; Amerena J; Atar D; Avezum Á; Blomström P; Borggrefe M; Budaj A; Chen SA; Ching CK; Commerford P; Dans A; Davy JM; Delacrétaz E; Di Pasquale G; Diaz R; Dorian P; Flaker G; Golitsyn S; Gonzalez-Hermosillo A; Granger CB; Heidbüchel H; Kautzner J; Kim JS; Lanas F; Lewis BS; Merino JL; Morillo C; Murin J; Narasimhan C; Paolasso E; Parkhomenko A; Peters NS; Sim KH; Stiles MK; Tanomsup S; Toivonen L; Tomcsányi J; Torp-Pedersen C; Tse HF; Vardas P; Vinereanu D; Xavier D; Zhu J; Zhu JR; Baret-Cormel L; Weinling E; Staiger C; Yusuf S; Chrolavicius S; Afzal R; Hohnloser SH;
N Engl J Med; 2011 Dec; 365(24):2268-76. PubMed ID: 22082198
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]